Axsome Therapeutics Inc

NASDAQ:AXSM  
76.54
-0.81 (-1.05%)
6:12:39 PM EDT: $78.00 +1.46 (+1.91%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)3.60B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$86.85 Million
Adjusted EPS-$1.30
See more estimates
10-Day MA$75.66
50-Day MA$73.72
200-Day MA$74.79
See more pivots

Axsome Therapeutics Inc Stock, NASDAQ:AXSM

One World Trade Center, 22nd floor, New York, New York 10007
United States of America
Phone: +1.212.332.3241
Number of Employees: 545

Description

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview contain AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.